Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Consequences of SARS-CoV2 Pandemic on Childhood Asthma Control and Exacerbations: French Multicenter Cross-sectional VIRASTHMA COVID G4 Study

NCT04821908 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT04821908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04821908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Consequences of SARS-CoV2 Pandemic on Childhood Asthma Control and Exacerbations: French Multicenter Cross-sectional VIRASTHMA COVID G4 Study
Lead sponsor
University Hospital, Lille
Phase
Observational
Overall status
Completed
Start date
September 14, 2021
Completion date
March 31, 2025
Enrollment
577 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma in children